This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

BNY Mellon Classic ADR Index(SM) 18% Return In 2012 Beats S&P 500, Led By Europe

Global FactorsWhile 2012 was characterized by a mixture of volatility, depressed equity prices and low interest rates,  China's GDP rebounded in the fourth quarter and BNY Mellon's forecast is for a slightly faster growth rate globally in 2013, said Kearns. (2)

"In this environment companies increasingly look beyond domestic markets and traditional financing centers for funding, and they have continued to tap international capital markets in a considerable way," Kearns added.

There were 31 capital-raising programs in 2012, including Russia's Sberbank, one of the largest DR offerings ever, as well as sizable and innovative programs for Russia's MegaFon and Brazil's BTG Pactual.

"Our recent investor relations survey shows that half of large cap companies from developed markets that are considering additional listings are interested in doing so in emerging markets," he said.

2012 Highlights include:
  • The BNY Mellon Classic ADR Index(SM) was up 18% for the year ending Dec. 31, 2012.  The top performing DR country indices were Germany with 33%, Australia with more than 25%, followed by China (+25%), France (+24%), and Switzerland (+22%)
  • The most actively traded U.S.-listed DRs by value included China's Baidu,  Brazil's Vale and Petrobras, and the U.K.'s BP and Vodafone 
  • Russian issuers continued to dominate the most actively traded DRs on the International Order Book (IOB), with Gazprom, Lukoil, Sberbank, Rosneft and Norilsk Nickel, the top five
  • The most active OTC-traded DR issues included Switzerland's Nestle and Roche, Russia's Gazprom, and BASF
  • 157 billion DRs worth $2.79 trillion traded, representing declines of 10% and 26%, respectively compared with 2011
  • 84 new sponsored DR programs were created
  • Almost $13 billion in capital was raised through 31 DR transactions, declines of 15% and 39%, respectively, over 2011

2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.43 0.46%
FB $102.74 3.20%
GOOG $691.41 2.00%
TSLA $148.86 0.41%
YHOO $27.43 2.30%


Chart of I:DJI
DOW 16,065.81 +51.43 0.32%
S&P 500 1,862.71 +10.50 0.57%
NASDAQ 4,314.62 +45.8570 1.07%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs